Unless otherwise noted, all Infravec2 products are shipped at biosafety level 1.

Modality of access

The European Council has delegated to Infravec2 the authority to identify and distribute key research resources for insect vectors to researchers in the European Research Area. The EC has funded the Infravec2 consortium to provide these resources at no cost to the user. Essentially, the Infravec2 project is an indirect form of targeted EC research funding for the insect vector research community. The Infravec2 consortium integrates the most advanced European vector biology infrastructures into a large virtual facility that has the capacity to redirect some of their own production for external access by the vector research community. The providing site is reimbursed by the project on an actual-cost basis for the resources provided.

Access to the Infravec2 research resources will be available for external users from academic research and commercial communities by means of the Infravec2 Portal, a web-based shopping site, available for use in August 2017. After saving items to the shopping cart, the check-out request will be made by uploading a brief justification that will be evaluated and prioritized by a selection committee. The Infravec2 product catalog will be available beginning later in 2017 for at least 4 years.

Who can access

Eligible researchers will be those in the EU, 16 associated European countries, and 130 developing countries (list here, http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/international-cooperation_en.htm).

Researchers in non-European developed countries are not eligible.


Products and resources are available from the Infravec2 Portal as Trans National Access activities (TNA). The TNA activities were selected according to two main benchmarks:

1) the criteria of INFRAIA-01-2016-2017 to represent “key research infrastructures of European interest.”

2) selection to fill the most important needs and gaps holding back vector research in the European Research Area, in part defined by a community survey (https://www.ncbi.nlm.nih.gov/pubmed/27677378).

The available research resources are grouped in three main categories.

  • Vectors. Newly-initiated fully characterized vector colonies, unique vector species, and field-collected vectors.
  • Derived and Infected Vector Products. Vectors infected under Containment Level CL2/CL3 conditions, and research services such as vector genetic analysis and genetic editing.
  • Facility access. This activity provides researcher direct physical access to the facility, to carry out studies involving behavior or insecticide exposure of vectors infected with CL2/CL3 pathogens.